![Chemical structure of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide, CAS 169590-42-5](https://api.angenesci.com/structure/3737/169590-42-5.png)
No data
No data
No data
| CAS Number | 169590-42-5 |
| Catalog Number | AG00HZBR(AGN-PC-0Q9I2P) |
| Chemical Name | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide |
| IUPAC Name | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
| InChI | InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25) |
| InChI Key | RZEKVGVHFLEQIL-UHFFFAOYSA-N |
| MDL Number | MFCD00941298 |
| Molecular Formula | C17H14F3N3O2S |
| Molecular Weight | 381.3722 |
| SMILES | C(F)(F)(F)c1nn(c(c1)c1ccc(cc1)C)c1ccc(cc1)S(=O)(=O)N |
| UNII | JCX84Q7J1L |
| Synonyms | 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
Celebrex,
celecoxib,
SC 58635,
SC-58635,
SC58635,
celecoxib,
169590-42-5,
Celebrex,
Celebra,
Onsenal,
Celocoxib,
SC 58635,
Celecox,
SC-58635,
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE,
YM177,
YM 177,
Celecoxibum,
HSDB 7038,
UNII-JCX84Q7J1L,
184007-95-2,
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,
SC58635,
C17H14F3N3O2S,
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide,
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
MFCD00941298,
YM-177,
CHEMBL118,
JCX84Q7J1L,
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide,
CHEBI:41423,
RZEKVGVHFLEQIL-UHFFFAOYSA-N,
NCGC00091455-01,
Xilebao,
DSSTox_CID_2777,
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide,
benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-,
DSSTox_RID_76725,
DSSTox_GSID_22777,
Celecoxib [USAN],
Celecoxi,
Solexa,
4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,
4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-,
Celebrex (TN),
SMR000550473,
CAS-169590-42-5,
SR-01000837528,
Celecoxib (SC-58635),
Celecoxib (JAN/USAN/INN),
Celecoxib [USAN:INN:BAN],
CCRIS 9330,
TPI-336,
Onsenal (TN),
AI-525,
CEP-33222,
CELEBCOXIB,
Spectrum_000432,
1oq5,
Spectrum2_001576,
Spectrum3_001996,
Spectrum4_000182,
Spectrum5_001324,
SC-58553, SC-58635,
AC1L1E6K,
Celecoxib/Celebrex, Celebra,
cid_2662,
SCHEMBL3708,
BSPBio_003596,
KBioGR_000723,
KBioGR_002351,
KBioSS_000912,
KBioSS_002354,
MLS001165684,
MLS001195656,
MLS001304708,
MLS006011862,
BIDD:GT0408,
DivK1c_000893,
SPECTRUM1503678,
SPBio_001512,
GTPL2892,
Celecoxib, >=98% (HPLC),
DTXSID0022777,
BDBM11639,
CTK8H4475,
HMS502M15,
KBio1_000893,
KBio2_000912,
KBio2_002351,
KBio2_003480,
KBio2_004919,
KBio2_006048,
KBio2_007487,
KBio3_002830,
KBio3_003037,
EX-A175,
SYN3015,
cMAP_000027,
NINDS_000893,
BCPP000290,
HMS1922G14,
HMS2089L18,
HMS2093I07,
HMS2234N18,
HMS3259L08,
HMS3261A14,
HMS3373A09,
HMS3654H09,
HMS3715F11,
Pharmakon1600-01503678,
ACT02648,
BCP02156,
EBD24636,
KS-00000FW2,
ZINC2570895,
Tox21_111135,
Tox21_201964,
Tox21_300599,
Tox21_500406,
US8741944, Comparative Compound,
ABP000291,
BBL029086,
CCG-39354,
NSC719627,
NSC758624,
s1261,
STL373576,
Celecoxib 1.0 mg/ml in Acetonitrile,
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide,
AKOS015842517,
Tox21_111135_1,
AC-4228,
AM84588,
AT-3762,
BCP9000507,
Celebrex, Celebra, 169590-42-5,
CS-0570,
DB00482,
KS-1041,
MCULE-4750749400,
NC00708,
NSC-719627,
NSC-758624,
RL02184,
SB19318,
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl),
IDI1_000893,
NCGC00091455-02,
NCGC00091455-03,
NCGC00091455-04,
NCGC00091455-05,
NCGC00091455-06,
NCGC00091455-07,
NCGC00091455-08,
NCGC00091455-09,
NCGC00091455-13,
NCGC00254540-01,
NCGC00259513-01,
NCGC00261091-01,
194044-54-7,
AK-60967,
AN-12211,
BC209720,
BP-30217,
CPD000550473,
HY-14398,
LS-31667,
NCI60_041049,
PHA-00846533,
SAM002589995,
SC-50829,
SBI-0051875.P002,
AB0012055,
CJ-016377,
CP-598107,
TL8001323,
UNM-0000305813,
FT-0080064,
FT-0601628,
FT-0623536,
FT-0700357,
SW199611-3,
PF-00345549,
A25046,
C-6317,
C07589,
D00567,
J10035,
AB00052396-07,
AB00052396-08,
AB00052396-09,
AB00052396_10,
AB00052396_11,
Celecoxib|169590-42-5|Celebrex|SC 58635,
590C425,
I01-1033,
J-010566,
J-520011,
Q-200816,
SR-01000837528-2,
SR-01000837528-3,
BRD-K02637541-001-02-4,
BRD-K02637541-001-06-5,
Z2210694606,
Celecoxib, European Pharmacopoeia (EP) Reference Standard,
Celecoxib, United States Pharmacopeia (USP) Reference Standard,
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide,
5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole,
Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material,
Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-,
Medicoxib,
Eurocox,
Celecoxib [Old RN],
Celebra (TN),
CEFUROXIME SODIUM,
Pfizer brand of celecoxib,
D03RTS,
Celebrex, Celebra, Celecoxib,
cc-518,
Celecoxib, 98% - 1g 1g,
CCRIS 8679,
CID2662,
ACN-029560,
CS-O-01154,
C17-H14-F3-N3-O2-S,
2-CHLORO-5-NITROPHENYLBORONIC ACID,
A1664,
C2816,
A10193,
C105934,
D000068579,
4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
CEL,
4-(5-(4-methylphenyl)-3-trifluoromethyl)-1h-pyrazol-yl)benzenesulfonamide,
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulphonamide,
4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide,
1000343-91-8,
CLX,
|
| Complexity | 577 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 381.076g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 26 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 381.373g/mol |
| Monoisotopic Mass | 381.076g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 86.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.4 |
| Symbol: | |
| Hazard Class | 9 |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | Ⅲ |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | UN 3077 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

